Pharmacokinetic interaction study of sulphasalazine in healthy subjects and the impact of curcumin as an in vivo inhibitor of BCRP

No abstract is available for this paper.

• Publication year

  2012

• Venue

  British Journal of Pharmacology

• Publication date

  2012-07-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1111/j.1476-5381.2012.01887.xPMID 22300367PMCID PMC3402804
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Microdosing Clinical Study: Pharmacokinetic, Pharmacogenomic (SLCO2B1), and Interaction (Grapefruit Juice) Profiles of Celiprolol Following the Oral Microdose and Therapeutic Dose

  2012cited by this paper
• Prediction of Nonlinear Intestinal Absorption of CYP3A4 and P-Glycoprotein Substrates from their In Vitro Km Values

  2012influential reference
• The effects of the SLCO2B1 c.1457C>T polymorphism and apple juice on the pharmacokinetics of fexofenadine and midazolam in humans

  2011cited by this paper
• Guide to Receptors and Channels (GRAC), 5th edition

  2011cited by this paper
• Orange and apple juice greatly reduce the plasma concentrations of the OATP2B1 substrate aliskiren.

  2011cited by this paper
• Membrane transporters in drug development

  2010cited by this paper
• Fruit juice inhibition of uptake transport: a new type of food-drug interaction.

  2010cited by this paper
• Influence of drug-transporter polymorphisms on the pharmacokinetics of fexofenadine enantiomers

  2010influential reference
• Guide to Receptors and Channels (GRAC), 4th edition

  2009cited by this paper
• Small intestinal efflux mediated by MRP2 and BCRP shifts sulfasalazine intestinal permeability from high to low, enabling its colonic targeting.

  2009cited by this paper
• Curcumin Inhibits the Activity of ABCG2/BCRP1, a Multidrug Resistance-Linked ABC Drug Transporter in Mice

  2009influential reference
• Physiological and pharmacological roles of ABCG2 (BCRP): recent findings in Abcg2 knockout mice.

  2009cited by this paper
• Method for predicting the risk of drug–drug interactions involving inhibition of intestinal CYP3A4 and P-glycoprotein

  2009influential reference
• ABCG2 Polymorphism Markedly Affects the Pharmacokinetics of Atorvastatin and Rosuvastatin

  2009cited by this paper
• Kinetic characterization of sulfasalazine transport by human ATP-binding cassette G2.

  2009influential reference
• Pharmacokinetics of Curcumin Conjugate Metabolites in Healthy Human Subjects

  2008cited by this paper
• Pharmacogenomic importance of ABCG2.

  2008cited by this paper
• Guide to Receptors and Channels (GRAC), 3rd edition

  2008cited by this paper
• Pharmacogenetic Characterization of Sulfasalazine Disposition Based on NAT2 and ABCG2 (BCRP) Gene Polymorphisms in Humans

  2008influential reference
• Intestinal efflux transporters and drug absorption.

  2008cited by this paper
• ATP-binding cassette, subfamily G (ABCG family)

  2007cited by this paper
• Effect of Breast Cancer Resistance Protein (Bcrp/Abcg2) on the Disposition of Phytoestrogens

  2007cited by this paper
• Intestinal Drug Transporter Expression and the Impact of Grapefruit Juice in Humans

  2007cited by this paper
• A Phase I, Randomized, Open-Label, Parallel-Cohort, Dose-Finding Study of Elacridar (GF120918) and Oral Topotecan in Cancer Patients

  2007cited by this paper
• Regional levels of drug transporters along the human intestinal tract: co-expression of ABC and SLC transporters and comparison with Caco-2 cells.

  2006influential reference
• Breast Cancer Resistance Protein (BCRP/ABCG2) is a Major Determinant of Sulfasalazine Absorption and Elimination in the Mouse

  2006influential reference
• Organic anion transporting polypeptide 2B1 is a high‐affinity transporter for atorvastatin and is expressed in the human heart

  2006influential reference
• Distribution of breast cancer resistance protein (BCRP/ABCG2) mRNA expression along the human GI tract.

  2005cited by this paper
• CONTRIBUTION OF OATP (ORGANIC ANION-TRANSPORTING POLYPEPTIDE) FAMILY TRANSPORTERS TO THE HEPATIC UPTAKE OF FEXOFENADINE IN HUMANS

  2005cited by this paper
• FUNCTIONAL ASSESSMENT OF ABCG2 (BCRP) GENE POLYMORPHISMS TO PROTEIN EXPRESSION IN HUMAN PLACENTA

  2005cited by this paper
• Effect of ABCG2 genotype on the oral vioavailability of topotecan

  2005cited by this paper
• Inhibition of multidrug resistance proteins MRP1 and MRP2 by a series of alpha,beta-unsaturated carbonyl compounds.

  2005cited by this paper
• Functional Analysis of SNPs Variants of BCRP/ABCG2

  2004influential reference
• Human extrahepatic cytochromes P450: function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts.

  2003cited by this paper
• Correlation of gene expression of ten drug efflux proteins of the ATP-binding cassette transporter family in normal human jejunum and in human intestinal epithelial Caco-2 cell monolayers.

  2001cited by this paper
• Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions.

  2001cited by this paper
• Active secretion and enterocytic drug metabolism barriers to drug absorption.

  2001cited by this paper
• Sulfasalazine. A review of its pharmacological properties and therapeutic efficacy in the treatment of rheumatoid arthritis.

  1995cited by this paper
• An analysis program MULTI(ELS) based on extended nonlinear least squares method for microcomputers.

  1986cited by this paper
• Sulfasalazine: Pharmacology, Clinical Use, Toxicity, and Related New Drug Development

  1984cited by this paper
• The disposition and metabolism of sulphasalazine (salicylazosulphapyridine) in man.

  1982influential reference
• Azo reduction of sulphasalazine in healthy volunteers.

  1982cited by this paper
• The role of intestinal bacteria in the metabolism of salicylazosulfapyridine.

  1972cited by this paper

• Curcumin Between Pleiotropic Potential and Translational Constraints

  2026cites this paper
• Food Additives Inhibit Intestinal Drug Transporters but Have Limited Effect on In Vitro Drug Permeability

  2025cites this paper
• Natural anti-cancer products: insights from herbal medicine

  2025cites this paper
• Meta-analysis and systematic review on Sulfasalazine/5-ASA use during pregnancy: Impact on neonatal and pregnancy outcomes.

  2025cites this paper
• Development, Optimization, and Evaluation of Nano Self-Emulsifying Drug Delivery System Formulation Platform for Oral Bioavailability Enhancement of Sulfasalazine and Disulfiram in Lung Cancer Chemoprevention

  2025cites this paper
• Plasma esketamine and noresketamine levels and antidepressant response with oral esketamine treatment.

  2025cites this paper
• A Pilot Study To Assess the Suitability of Riboflavin As a Surrogate Marker of Breast Cancer Resistance Protein in Healthy Participants

  2024cites this paper
• Use of over-the-counter supplements, sleep aids and analgesic medicines in rheumatology: results of a cross-sectional survey

  2024cites this paper
• Clinical Assessment of Breast Cancer Resistance Protein (BCRP)-Mediated Drug–Drug Interactions of Sepiapterin with Curcumin and Rosuvastatin in Healthy Volunteers

  2024influential citation
• Drug Interaction-Informed Approaches to Inflammatory Bowel Disease Management

  2024influential citation
• Bacterial Influence on Pharmacokinetics of Tacrolimus and Sulfasalazine through Regulation of Host Metabolism

  2024cites this paper
• Natural Product Use Among Veterans with Chronic Pain: A Qualitative Study of Attitudes and Communication with Healthcare Providers

  2024cites this paper
• Enhanced absorption of prenylated cinnamic acid derivatives from Brazilian green propolis by turmeric in humans and rats

  2024cites this paper
• Role of Turmeric and Curcumin in Prevention and Treatment of Chronic Diseases: Lessons Learned from Clinical Trials.

  2023cites this paper
• Interplay of Breast Cancer Resistance Protein (Bcrp/Abcg2), Sex, and Fed State in Oral Pharmacokinetic Variability of Furosemide in Rats

  2023cites this paper
• An Overview of the Enhanced Effects of Curcumin and Chemotherapeutic Agents in Combined Cancer Treatments

  2023cites this paper
• Hot-Melt Extrusion as an Effective Technique for Obtaining an Amorphous System of Curcumin and Piperine with Improved Properties Essential for Their Better Biological Activities

  2023cites this paper
• Exploring the effect of different linkers on self-assembly, ROS-sensitivity and anticancer efficacy of hydroxyethyl starch-curcumin prodrug

  2023cites this paper
• Potential pharmacokinetic interactions with concurrent use of herbal medicines and a ritonavir-boosted COVID-19 protease inhibitor in low and middle-income countries

  2023cites this paper
• Practical Approaches to Pharmacogenomics in Patients Using Vitamins/Supplements and Medical Marijuana

  2023cites this paper
• Curcumin: The Golden Nutraceutical on the Road to Cancer Prevention and Therapeutics. A Clinical Perspective.

  2022cites this paper
• Cynomolgus Monkey as an Emerging Animal Model to Study Drug Transporters: In Vitro, In Vivo, In Vitro-to-In Vivo Translation

  2021influential citation
• Transporter-mediated Natural Product-Drug Interactions

  2021cites this paper
• Negligible Effect of Quercetin in the Pharmacokinetics of Sulfasalazine in Rats and Beagles: Metabolic Inactivation of the Interaction Potential of Quercetin with BCRP

  2021cites this paper
• Role of Membrane Transporters in Drug Disposition

  2021cites this paper
• Quantitative prediction of pharmacokinetic properties of drugs in humans: Recent advance in in vitro models to predict the impact of efflux transporters in the small intestine and blood-brain barrier.

  2021cites this paper
• Classification of drugs for evaluating drug interaction in drug development and clinical management.

  2021cites this paper
• Current clinical developments in curcumin‐based therapeutics for cancer and chronic diseases

  2021cites this paper
• Zebrafish (Danio rerio) Oatp2b1 as a functional ortholog of the human OATP2B1 transporter

  2021cites this paper
• Curcumin loaded drug delivery systems in the treatment of liver diseases

  2021cites this paper
• OATP2B1 - the underrated member of the Organic Anion Transporting Polypeptide Family of drug transporters?

  2021cites this paper
• Food constituent– and herb–drug interactions in oncology: Influence of quantitative modelling on Drug labelling

  2021cites this paper
• Effect of P-glycoprotein (P-gp) Inducers on Exposure of P-gp Substrates: Review of Clinical Drug–Drug Interaction Studies

  2020cites this paper
• In vitro and in vivo Study of a Novel Liposome-Mediated Dual Drug Delivery for Synergistic Lung Cancer Therapy via Oral Administration

  2020cites this paper
• The impact of breast cancer resistant protein (BCRP/ABCG2) on drug transport across Caco-2 cell monolayers.

  2020influential citation
• An Update on the Pharmacological Usage of Curcumin: Has it Failed in the Drug Discovery Pipeline?

  2020cites this paper
• Interactions of Oral Molecular Excipients with Breast Cancer Resistance Protein, BCRP.

  2020cites this paper
• Physiologically-Based Pharmacokinetic Predictions of the Effect of Curcumin on Metabolism of Imatinib and Bosutinib: In Vitro and In Vivo Disconnect

  2020cites this paper
• Quercetin Is a Flavonoid Breast Cancer Resistance Protein Inhibitor with an Impact on the Oral Pharmacokinetics of Sulfasalazine in Rats

  2020influential citation
• Transcription factor-mediated regulation of the BCRP/ABCG2 efflux transporter: a review across tissues and species

  2020cites this paper
• Human variability in influx and efflux transporters in relation to uncertainty factors for chemical risk assessment.

  2020cites this paper
• Characterization of the Human Intestinal Drug Transport with Ussing Chamber System Incorporating Freshly Isolated Human Jejunum

  2020cites this paper
• Novel insights into the organic solute transporter alpha/beta, OSTα/β: From the bench to the bedside.

  2020cites this paper
• Development and Validation of a Simultaneous Bioanalytical Method for Methotrexate, Sulfasalazine and Hydroxychloroquine in Rat Plasma following Single Step Protein Precipitation Technique

  2020cites this paper
• System xc− in microglia is a novel therapeutic target for post-septic neurological and psychiatric illness

  2019cites this paper
• Structure-Activity Relationships of Efflux Transporter Inhibitors

  2019influential citation
• Analysis of membrane transport mechanisms of endogenous substrates using chromatographic techniques.

  2019cites this paper
• Stimulatory effect on the transport mediated by organic anion transporting polypeptide 2B1

  2019cites this paper
• Effect of Osmolality on the Pharmacokinetic Interaction between Apple Juice and Atenolol in Rats

  2019cites this paper
• Inhibitors of Human ABCG2: From Technical Background to Recent Updates With Clinical Implications

  2019influential citation
• ABCG2/BCRP: variants, transporter interaction profile of substrates and inhibitors

  2019cites this paper
• Microdosing clinical study to clarify pharmacokinetic and pharmacogenetic characteristics of atorvastatin in Japanese hypercholesterolemic patients.

  2019cites this paper
• Evaluation of inhibitory effects of flavonoids on breast cancer resistance protein (BCRP): From library screening to biological evaluation to structure-activity relationship.

  2019cites this paper
• Strategy for improved therapeutic efficiency of curcumin in the treatment of gastric cancer.

  2019cites this paper
• Is curcumin bioavailability a problem in humans: lessons from clinical trials

  2019cites this paper
• Drugs and Food Interactions: Food–Drug Interactions Among the Elderly: Risk Assessment and Recommendations for Patients

  2019cites this paper
• Intracellular Delivery of Natural Antioxidants via Hyaluronan Nanohydrogels

  2019cites this paper
• Pheophorbide A: Fluorescent Bcrp Substrate to Measure Oral Drug-Drug Interactions in Real-Time In Vivo

  2018cites this paper
• Application of Intestinal Epithelial Cells Differentiated from Human Induced Pluripotent Stem Cells for Studies of Prodrug Hydrolysis and Drug Absorption in the Small Intestine

  2018cites this paper
• Efflux excretion of bisdemethoxycurcumin‐O‐glucuronide in UGT1A1‐overexpressing HeLa cells: Identification of breast cancer resistance protein (BCRP) and multidrug resistance‐associated proteins 1 (MRP1) as the glucuronide transporters

  2018cites this paper
• Clinical Probes and Endogenous Biomarkers as Substrates for Transporter Drug‐Drug Interaction Evaluation: Perspectives From the International Transporter Consortium

  2018cites this paper
• Relevance of Breast Cancer Resistance Protein to Pharmacokinetics of Florfenicol in Chickens: A Perspective from In Vivo and In Vitro Studies

  2018cites this paper
• Preclinical absorption, distribution, metabolism, excretion and pharmacokinetics of a novel selective inhibitor of breast cancer resistance protein (BCRP)

  2018influential citation
• Similar effect of quercetin on CYP2E1 and CYP2C9 activities in humans?

  2018cites this paper
• Curcumin as an In Vivo Selective Intestinal Breast Cancer Resistance Protein Inhibitor in Cynomolgus Monkeys

  2018influential citation
• ALSUntangled 44: curcumin

  2018cites this paper
• Ketamine Pharmacokinetics and Pharmacodynamics Are Altered by P-Glycoprotein and Breast Cancer Resistance Protein Efflux Transporters in Mice

  2018cites this paper
• Ketamine pharmacokinetics and pharmacodynamics are altered by Pgp and Bcrp efflux transporters in mice

  2018cites this paper
• High Expression of UGT1A1/1A6 in Monkey Small Intestine: Comparison of Protein Expression Levels of Cytochromes P450, UDP-Glucuronosyltransferases, and Transporters in Small Intestine of Cynomolgus Monkey and Human.

  2018cites this paper
• Preventive Effect of Curcumin Against Chemotherapy-Induced Side-Effects

  2018cites this paper
• Simultaneous Assessment of Transporter-Mediated Drug–Drug Interactions Using a Probe Drug Cocktail in Cynomolgus Monkey

  2018cites this paper
• Evaluation of Alteration in Hepatic and Intestinal BCRP Function In Vivo from ABCG2 c.421C>A Polymorphism Based on PBPK Analysis of Rosuvastatin

  2018cites this paper
• Kurkumin u kliničkim istraživanjima

  2017cites this paper
• Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases

  2017cites this paper
• Common Herbal Dietary Supplement-Drug Interactions.

  2017cites this paper
• Small-Dosing Clinical Study: Pharmacokinetic, Pharmacogenomic (SLCO2B1 and ABCG2), and Interaction (Atorvastatin and Grapefruit Juice) Profiles of 5 Probes for OATP2B1 and BCRP.

  2017cites this paper
• Intestinal Drug Interactions Mediated by OATPs: A Systematic Review of Preclinical and Clinical Findings.

  2017cites this paper
• Hepatocyte-Specific Deletion of EGFR in Mice Reduces Hepatic Abcg2 Transport Activity Measured by [11C]erlotinib and Positron Emission Tomography

  2017cites this paper
• Curcumin as a clinically-promising anti-cancer agent: pharmacokinetics and drug interactions

  2017cites this paper
• Evidence against the participation of a pharmacokinetic interaction in the protective effect of single-dose curcumin against gastrointestinal damage induced by indomethacin in rats.

  2017cites this paper
• Evaluation of transporters in drug development: Current status and contemporary issues☆

  2017cites this paper
• Drug-Herb Interactions in the Elderly Patient with IBD: a Growing Concern

  2017cites this paper
• Curcumin Pretreatment Decreases Absorption of Phenacetin (Cytochrome P450 1A2 Substrate), Without Altering its Disposition Kinetics in Rats

  2017cites this paper
• The effects of dietary and herbal phytochemicals on drug transporters☆

  2017cites this paper
• Interaction of Food Additives with Intestinal Efflux Transporters.

  2017cites this paper
• Expression, regulation and function of intestinal drug transporters: an update

  2017cites this paper
• In Vitro Evaluation of the Pharmacokinetic Effects of BCRP Interactions

  2017influential citation
• In vitro evaluation of the pharmacokinetic effects of BCRP interactions

  2017cites this paper
• Evaluation of Proposed In Vivo Probe Substrates and Inhibitors for Phenotyping Transporter Activity in Humans

  2016cites this paper
• Exposure Data 1 . 1 Identification of the agent 1

  2016cites this paper
• Generation and Characterization of a Breast Cancer Resistance Protein Humanized Mouse Model

  2016cites this paper
• Explication of Definitional Description and Empirical Use of Fraction of Orally Administered Drugs Absorbed From the Intestine (Fa) and Intestinal Availability (Fg): Effect of P-glycoprotein and CYP3A on Fa and Fg.

  2016cites this paper
• Effect of Curcumin on Sulfasalazine Pharmacokinetics in Healthy Volunteers

  2016cites this paper
• Transporter modulation by Chinese herbal medicines and its mediated pharmacokinetic herb-drug interactions.

  2016cites this paper
• Some Drugs and Herbal Products.

  2016cites this paper
• Curcumin Affects Phase II Disposition of Resveratrol Through Inhibiting Efflux Transporters MRP2 and BCRP

  2016cites this paper
• A novel pharmacokinetic model based on the complex elimination of monoclonal antibodies for bevacizumab pharmacokinetic study in rabbits.

  2016cites this paper
• Quantitative Targeted Absolute Proteomics of Transporters and Pharmacoproteomics-Based Reconstruction of P-Glycoprotein Function in Mouse Small Intestine.

  2016cites this paper
• Spices for Prevention and Treatment of Cancers

  2016cites this paper
• Development of an optimized hyaluronic acid-based lipidic nanoemulsion co-encapsulating two polyphenols for nose to brain delivery

  2016cites this paper